Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery

British Journal of Pharmacology

Volumn 171, Issue 24, 2014, Pages 5816-5828

  Putula, Jaana ^a   Pihlajamaa, Tero ^b   Kukkonen, Jyrki P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DYNAMIN; OREXIN; OREXIN A; OREXIN RECEPTOR; PHOSPHOLIPASE C; CALCIUM; HCRT PROTEIN, HUMAN; HCRTR1 PROTEIN, HUMAN; NEUROPEPTIDE; PROTEIN BINDING; SIGNAL PEPTIDE;

ARTICLE; BINDING KINETICS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CULTURE; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; LIGAND BINDING; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RECEPTOR BINDING; SCINTILLATION; SIGNAL TRANSDUCTION; ANIMAL; CHO CELL LINE; CRICETULUS; METABOLISM;

ANIMALS; CALCIUM; CHO CELLS; CRICETULUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OREXIN RECEPTORS; OREXINS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 84919346511     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12883     Document Type: Article

References (64)

1. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013a). The concise guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol 170: 1449-1458.
2. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013b). The concise guide to PHARMACOLOGY 2013/14: G-protein coupled receptors. Br J Pharmacol 170: 1459-1581.
3. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013c). The concise guide to PHARMACOLOGY 2013/14: Ion channels. Br J Pharmacol 170: 1607-1651.
4. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013d). The concise guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
5. Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M, et al. (2003). Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther 305: 507-514.
6. Ammoun S, Johansson L, Ekholm ME, Holmqvist T, Danis AS, Korhonen L, et al. (2006). OX1 orexin receptors activate extracellular signal-regulated kinase (ERK) in CHO cells via multiple mechanisms: the role of Ca2+ influx in OX1 receptor signaling. Mol Endocrinol 20: 80-99.
7. Ananthanarayanan VS, Kerman A, (2006). Role of metal ions in ligand-receptor interaction: insights from structural studies. Mol Cell Endocrinol 246: 53-59.
8. Brooks SP, Storey KB, (1992). Bound and determined: a computer program for making buffers of defined ion concentrations. Anal Biochem 201: 119-126.
9. Brown RE, Sergeeva OA, Eriksson KS, Haas HL, (2002). Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22: 8850-8859.
10. Burdakov D, Liss B, Ashcroft FM, (2003). Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci 23: 4951-4957.
11. Burlet S, Tyler CJ, Leonard CS, (2002). Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22: 2862-2872.
12. Chaudhry C, Plested AJ, Schuck P, Mayer ML, (2009). Energetics of glutamate receptor ligand binding domain dimer assembly are modulated by allosteric ions. Proc Natl Acad Sci U S A 106: 12329-12334.
13. Cooper MA, (2004). Advances in membrane receptor screening and analysis. J Mol Recognit 17: 286-315.
14. Ekholm ME, Johansson L, Kukkonen JP, (2007). IP(3)-independent signalling of OX(1) orexin/hypocretin receptors to Ca(2+) influx and ERK. Biochem Biophys Res Commun 353: 475-480.
15. Fass D, Blacklow S, Kim PS, Berger JM, (1997). Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 388: 691-693.
16. Hatta K, Nose A, Nagafuchi A, Takeichi M, (1988). Cloning and expression of cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in the cadherin gene family. J Cell Biol 106: 873-881.
17. Holmqvist T, Åkerman KEO, Kukkonen JP, (2002). Orexin signaling in recombinant neuron-like cells. FEBS Lett 526: 11-14.
18. Holmqvist T, Johansson L, Östman M, Ammoun S, Åkerman KE, Kukkonen JP, (2005). OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280: 6570-6579.
19. Hsu CY, Persons PE, Spada AP, Bednar RA, Levitzki A, Zilberstein A, (1991). Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue. J Biol Chem 266: 21105-21112.
20. Ishibashi M, Takano S, Yanagida H, Takatsuna M, Nakajima K, Oomura Y, et al. (2005). Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. Peptides 26: 471-481.
21. Jäntti MH, Putula J, Somerharju P, Frohman MA, Kukkonen JP, (2012). OX(1) orexin/hypocretin receptor activation of phospholipase D. Br J Pharmacol 165: 1109-1123.
22. Jäntti MH, Putula J, Turunen PM, Näsman J, Reijonen S, Kukkonen JP, (2013). Autocrine endocannabinoid signaling potentiates orexin receptor signaling upon CB1 cannabinoid-OX1 orexin receptor coexpression. Mol Pharmacol 83: 621-632.
23. Järv J, Hedlund B, Bartfai T, (1979). Isomerization of the muscarinic receptor. antagonist complex. J Biol Chem 254: 5595-5598.
24. Johansson L, Ekholm ME, Kukkonen JP, (2007). Regulation of OX(1) orexin/hypocretin receptor-coupling to phospholipase C by Ca(2+) influx. Br J Pharmacol 150: 97-104.
25. Kim HY, Hong E, Kim JI, Lee W, (2004). Solution structure of human orexin-A: regulator of appetite and wakefulness. J Biochem Mol Biol 37: 565-573.
26. Kohlmeier KA, Inoue T, Leonard CS, (2004). Hypocretin/orexin peptide signalling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol 92: 221-235.
27. Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS, (2008). Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 100: 2265-2281.
28. Konieczny V, Keebler MV, Taylor CW, (2012). Spatial organization of intracellular Ca2+ signals. Semin Cell Dev Biol 23: 172-180.
29. Kopanchuk S, Veiksina S, Petrovska R, Mutule I, Szardenings M, Rinken A, et al. (2005). Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites. Eur J Pharmacol 512: 85-95.
30. Kukkonen JP, (2011). A ménage à trois made in heaven: G-protein-coupled receptors, lipids and TRP channels. Cell Calcium 50: 9-26.
31. Kukkonen JP, (2013). Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 301: C2-C32.
32. Kukkonen JP, (2014). Lipid signaling cascades of orexin/hypocretin receptors. Biochimie 96: 158-165.
33. Kukkonen JP, Åkerman KEO, (2001). Orexin receptors couple to Ca2+ channels different from store-operated Ca2+ channels. Neuroreport 12: 2017-2020.
34. Kukkonen JP, Leonard CS, (2014). Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 171: 294-313.
35. Larsson KP, Peltonen HM, Bart G, Louhivuori LM, Penttonen A, Antikainen M, et al. (2005). Orexin-A-induced Ca2+ entry: evidence for involvement of TRPC channels and protein kinase C regulation. J Biol Chem 280: 1771-1781.
36. Leonard CS, Kukkonen JP, (2014). Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 171: 294-313.
37. Levay K, Satpaev DK, Pronin AN, Benovic JL, Slepak VZ, (1998). Localization of the sites for Ca2+-binding proteins on G protein-coupled receptor kinases. Biochemistry 37: 13650-13659.
38. Liu RJ, van den Pol AN, Aghajanian GK, (2002). Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22: 9453-9464.
39. Louhivuori LM, Jansson L, Nordstrom T, Bart G, Nasman J, Akerman KE, (2010). Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway. Cell Calcium 48: 114-123.
40. Lu Y, Yeung N, Sieracki N, Marshall NM, (2009). Design of functional metalloproteins. Nature 460: 855-862.
41. Lund PE, Shariatmadari R, Uustare A, Detheux M, Parmentier M, Kukkonen JP, et al. (2000). The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem 275: 30806-30812.
42. Miskolzie M, Kotovych G, (2003). The NMR-derived conformation of orexin-A: an orphan G-protein coupled receptor agonist involved in appetite regulation and sleep. J Biomol Struct Dyn 21: 201-210.
43. Nakamura Y, Miura S, Yoshida T, Kim J, Sasaki K, (2010). Cytosolic calcium elevation induced by orexin/hypocretin in granule cell domain cells of the rat cochlear nucleus in vitro. Peptides 31: 1579-1588.
44. Näsman J, Bart G, Larsson K, Louhivuori L, Peltonen H, Åkerman KE, (2006). The orexin OX1 receptor regulates Ca2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells. J Neurosci 26: 10658-10666.
45. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res 42 (Database Issue): D1098-D1106.
46. Peggion E, Mammi S, Palumbo M, Moroder L, Wunsch E, (1983). Interaction of calcium ions with peptide hormones of the gastrin family. Biopolymers 22: 2443-2457.
47. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB, (1998). Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18: 7962-7971.
48. van den Pol AN, Ghosh PK, Liu RJ, Li Y, Aghajanian GK, Gao XB, (2002). Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 541: 169-185.
49. Putula J, Turunen PM, Johansson L, Näsman J, Ra R, Korhonen L, et al. (2011). Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction. FEBS Lett 585: 1368-1374.
50. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
51. Sallese M, Iacovelli L, Cumashi A, Capobianco L, Cuomo L, De Blasi A, (2000). Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins. Biochim Biophys Acta 1498: 112-121.
52. Salomon Y, (1990). Melanocortin receptors: targets for control by extracellular calcium. Mol Cell Endocrinol 70: 139-145.
53. Siemion IZ, Jankowski A, Sobczyk K, Szewczuk Z, (1985). Mode of calcium binding to enkephalins. Int J Pept Protein Res 25: 225-336.
54. Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F, et al. (1999). Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol 128: 1-3.
55. Takai T, Takaya T, Nakano M, Akutsu H, Nakagawa A, Aimoto S, et al. (2006). Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor. J Pept Sci 12: 443-454.
56. Tosetti P, Pathak N, Jacob MH, Dunlap K, (2003). RGS3 mediates a calcium-dependent termination of G protein signaling in sensory neurons. Proc Natl Acad Sci U S A 100: 7337-7342.
57. Turunen PM, Jäntti MH, Kukkonen JP, (2012). OX1 orexin/hypocretin receptor signaling via arachidonic acid and endocannabinoid release. Mol Pharmacol 82: 156-167.
58. Uramura K, Funahashi H, Muroya S, Shioda S, Takigawa M, Yada T, (2001). Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 12: 1885-1889.
59. Wu M, Zhang Z, Leranth C, Xu C, van den Pol AN, Alreja M, (2002). Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J Neurosci 22: 7754-7765.
60. Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M, (2004). Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 24: 3527-3536.
61. Xu TR, Ward RJ, Pediani JD, Milligan G, (2011). The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochem J 439: 171-183.
62. Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M, (2010). Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci 30: 12642-12652.
63. Yang B, Ferguson AV, (2002). Orexin-A depolarizes dissociated rat area postrema neurons through activation of a nonselective cationic conductance. J Neurosci 22: 6303-6308.
64. Yang B, Samson WK, Ferguson AV, (2003). Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C. J Neurosci 23: 6215-6222.